Vivani Medical, Inc.
VANINasdaq
$1.32
↓ -2.2%Jul 17 close · end-of-day
Price
1Y↓ -18.5%
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Key statistics
Market Cap
$107.3M
Enterprise Value
$87.5M
P/E
—
P/S
—
P/B
5.6
EV/EBITDA
—
PEG
—
FCF Yield
-24.7%
Dividend Yield
—
Revenue (TTM)
—
Net Income (TTM)
$26.1M
Free Cash Flow (TTM)
-$26.5M
Gross Margin
—
Operating Margin
—
Net Margin
—
ROE
136.9%
ROIC
—
Debt / Equity
—
Net Cash
$19.7M
Return 1Y
-17.0%
Company profile
Second Sight Medical Products, Inc. develops implantable visual prosthetics intended to deliver artificial vision to blind individuals. Orion Visual Cortical Prosthesis System, an implanted cortical stimulation device, is intended to provide useful artificial vision. The company was founded in 1998 and is headquartered in Sylmar, California.
- CEO
- Adam Mendelsohn
- Sector
- Manufacturing
- Industry
- Medical Equipment
- Employees
- 20
- Headquarters
- California
- Website
- vivani.com
Earnings
VANI Q1 2026 Earnings
Period ends 2026-03-31
MetricActualYoY
Revenue——
Diluted EPS-$0.08↓ -27.3%
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
Financial statements
| Line item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | $0.00 | $0.00 |
| Gross profit | $500,000.00 | $130,000.00 | — | — | — | — |
| Operating income | -$14.9M | -$13.3M | -$21.2M | -$27.0M | -$24.7M | -$27.6M |
| Net income | -$14.9M | -$12.8M | -$13.9M | $25.7M | $23.5M | $26.6M |
| Diluted EPS | — | — | — | -$0.50 | -$0.43 | -$0.43 |
| Operating cash flow | -$16.8M | -$11.0M | -$18.8M | -$23.7M | -$20.8M | -$24.3M |
| Free cash flow | -$17.2M | -$11.5M | -$19.1M | -$24.6M | -$21.3M | -$25.5M |
| Gross margin | — | — | — | — | — | — |
| Operating margin | — | — | — | — | — | — |
| Net margin | — | — | — | — | — | — |
| Line item | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | $0.00 | — | $0.00 | $0.00 | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | -$5.7M | -$6.3M | -$6.5M | -$6.6M | -$7.5M | -$6.7M | -$6.8M | -$6.8M |
| Net income | -$5.4M | -$6.0M | $40.9M | -$6.3M | -$7.1M | -$6.5M | $46.6M | -$6.8M |
| Diluted EPS | -$0.10 | -$0.11 | -$0.10 | -$0.11 | -$0.12 | -$0.11 | -$0.09 | -$0.08 |
| Operating cash flow | -$4.8M | -$5.7M | -$5.8M | -$5.2M | -$6.1M | -$6.4M | -$6.7M | -$6.2M |
| Free cash flow | -$4.8M | -$5.7M | -$6.1M | -$5.2M | -$6.2M | -$7.2M | -$7.0M | -$6.2M |
| Gross margin | — | — | — | — | — | — | — | — |
| Operating margin | — | — | — | — | — | — | — | — |
| Net margin | — | — | — | — | — | — | — | — |
Company news
Jul 15, 2026
Jul 14, 2026
Jul 9, 2026
Analyst estimates
Coming soonConsensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
Insider transactions
BoughtSoldMonthly insider $ volume · trailing 12 months
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-07-15 | Williams Gregg | Buy | 793,650 | $1.26 | $999,999.00 | filing |
| 2026-06-15 | Williams Gregg | Buy | 1,587,301 | $1.26 | $2.0M | filing |
| 2026-05-15 | Williams Gregg | Buy | 1,587,301 | $1.26 | $2.0M | filing |
| 2026-04-15 | Williams Gregg | Buy | 1,587,301 | $1.26 | $2.0M | filing |
| 2026-03-15 | Williams Gregg | Buy | 1,310,680 | $1.03 | $1.4M | filing |
| 2026-03-15 | Williams Gregg | Buy | 264,551 | $1.26 | $333,334.26 | filing |
| 2026-02-15 | Williams Gregg | Buy | 1,601,941 | $1.03 | $1.6M | filing |
| 2026-02-15 | Williams Gregg | Buy | 264,551 | $1.26 | $333,334.26 | filing |
| 2026-01-27 | Williams Gregg | Buy | 1,351,351 | $1.48 | $2.0M | filing |
| 2026-01-15 | Williams Gregg | Buy | 1,473,214 | $1.12 | $1.6M | filing |
| 2026-01-15 | Williams Gregg | Buy | 264,551 | $1.26 | $333,334.26 | filing |
| 2025-12-15 | Williams Gregg | Buy | 1,473,214 | $1.12 | $1.6M | filing |
| 2025-12-15 | Williams Gregg | Buy | 264,551 | $1.26 | $333,334.26 | filing |
| 2025-11-15 | Williams Gregg | Buy | 1,473,214 | $1.12 | $1.6M | filing |
| 2025-11-15 | Williams Gregg | Buy | 264,550 | $1.26 | $333,333.00 | filing |
| 2025-10-27 | Williams Gregg | Buy | 3,703,703 | $1.62 | $6.0M | filing |
| 2025-10-15 | Williams Gregg | Buy | 1,473,214 | $1.12 | $1.6M | filing |
| 2025-10-15 | Williams Gregg | Buy | 264,550 | $1.26 | $333,333.00 | filing |
| 2025-09-15 | Williams Gregg | Buy | 1,473,215 | $1.12 | $1.7M | filing |
| 2025-09-15 | Williams Gregg | Buy | 595,238 | $1.26 | $749,999.88 | filing |
Latest 20 transactions.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.